Start-Up Success Stories

Cellbyte

Cellbyte is an AI-native platform for Pricing & Market Access (P&MA) teams in the pharmaceutical industry. They help companies accelerate and de-risk their drug launch strategies by giving instant access to critical insights from clinical, regulatory, HTA, and pricing data. Instead of spending weeks researching across fragmented sources, teams can now extract evidence-based answers in seconds through their intuitive (chat) interface. For vaccines and biotech, this means faster, more confident decision-making on pricing, reimbursement, and global market access - areas that are often bottlenecks for innovation reaching patients. 

Cellbyte first exhibited & presented as a start-up in 2024 at World Orphan Drug Congress Europe and has since grown to join the World Vaccine Congress Europe. They will return at World Vaccine Congres Europe in 2026.

"Being in the Start-Up Zone allows us to connect directly with innovators, policymakers, and industry leaders."

  Felix Steinbrenner, Co-CEO & Co-Founder, CellByte

Want to learn from their success? Download the Full Success Story and see what they had to say!